electroCore (NASDAQ:ECOR) Now Covered by Brookline Capital Acquisition

Brookline Capital Acquisition initiated coverage on shares of electroCore (NASDAQ:ECOR – Get Rating) in a research note issued to investors on Friday, Benzinga reports. The brokerage set a “buy” rating on the stock.

Separately, Berenberg Bank lowered their price target on electroCore from GBX 390 ($4.76) to GBX 330 ($4.03) and set a “buy” rating for the company in a research report on Thursday, October 6th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $111.42.

electroCore Stock Up 0.5 %

Shares of electroCore stock traded up $0.00 on Friday, hitting $0.30. The stock had a trading volume of 1,669 shares, compared to its average volume of 125,556. electroCore has a one year low of $0.20 and a one year high of $0.90. The stock’s 50-day simple moving average is $0.30 and its two-hundred day simple moving average is $7.80.

electroCore (NASDAQ:ECOR – Get Rating) last announced its quarterly earnings results on Thursday, November 3rd. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.01). electroCore had a negative net margin of 283.41% and a negative return on equity of 72.36%. The firm had revenue of $1.98 million for the quarter. Equities research analysts forecast that electroCore will post -0.3 EPS for the current year.

Insider Activity

In related news, Director Joseph P. Errico purchased 100,000 shares of the firm’s stock in a transaction that occurred on Wednesday, November 16th. The stock was bought at an average cost of $0.29 per share, with a total value of $29,000.00. Following the completion of the purchase, the director now directly owns 2,068,854 shares in the company, valued at $599,967.66. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last 90 days, insiders have purchased 670,000 shares of company stock valued at $186,650. Corporate insiders own 13.11% of the company’s stock.

Institutional Investors Weigh In On electroCore

Several hedge funds have recently made changes to their positions in the company. Valeo Financial Advisors LLC lifted its position in electroCore by 1.2% during the second quarter. Valeo Financial Advisors LLC now owns 1,844,500 shares of the company’s stock valued at $941,000 after buying an additional 22,250 shares during the period. Jaffetilchin Investment Partners LLC boosted its stake in electroCore by 31.6% during the first quarter. Jaffetilchin Investment Partners LLC now owns 307,984 shares of the company’s stock worth $82,000 after acquiring an additional 74,000 shares in the last quarter. Millennium Management LLC grew its holdings in electroCore by 173.3% in the second quarter. Millennium Management LLC now owns 119,707 shares of the company’s stock worth $61,000 after purchasing an additional 75,908 shares during the period. Virtu Financial LLC purchased a new stake in electroCore in the first quarter worth about $53,000. Finally, Renaissance Technologies LLC increased its stake in shares of electroCore by 102.2% during the second quarter. Renaissance Technologies LLC now owns 262,848 shares of the company’s stock valued at $134,000 after purchasing an additional 132,848 shares in the last quarter. 17.76% of the stock is currently owned by institutional investors.

electroCore Company Profile

(Get Rating)

electroCore, Inc, a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.